Hartford Creative Group Reports Officer/Director Changes
Ticker: HFUS · Form: 8-K · Filed: Oct 9, 2024 · CIK: 1482554
| Field | Detail |
|---|---|
| Company | Hartford Creative Group, INC. (HFUS) |
| Form Type | 8-K |
| Filed Date | Oct 9, 2024 |
| Risk Level | medium |
| Pages | 3 |
| Reading Time | 3 min |
| Key Dollar Amounts | $0.001 |
| Sentiment | neutral |
Sentiment: neutral
Topics: management-change, corporate-governance
Related Tickers: HCGI
TL;DR
Hartford Creative Group (HCGI) filed an 8-K for officer/director changes on 10/7.
AI Summary
Hartford Creative Group, Inc. filed an 8-K on October 9, 2024, reporting changes as of October 7, 2024. The filing pertains to the departure of directors or certain officers, election of directors, appointment of certain officers, and compensatory arrangements of certain officers. Specific details regarding these changes were not provided in the initial filing header.
Why It Matters
This filing indicates potential shifts in the company's leadership and governance structure, which could impact strategic direction and operational oversight.
Risk Assessment
Risk Level: medium — Changes in key leadership roles can introduce uncertainty and signal underlying issues or strategic realignments.
Key Players & Entities
- Hartford Creative Group, Inc. (company) — Registrant
- October 7, 2024 (date) — Earliest event reported
- October 9, 2024 (date) — Filing date
- Nevada (jurisdiction) — State of incorporation
- 8832 Glendon Way, Rosemead, California 91770 (address) — Principal executive offices
FAQ
What specific changes occurred regarding directors or officers?
The filing indicates the departure of directors or certain officers, election of directors, and appointment of certain officers, but the specific names and details are not provided in the initial header.
What is the effective date of the reported changes?
The earliest event reported is dated October 7, 2024.
When was this 8-K filing submitted to the SEC?
The filing was submitted on October 9, 2024.
What is Hartford Creative Group, Inc.'s state of incorporation?
The company is incorporated in Nevada.
Where are Hartford Creative Group, Inc.'s principal executive offices located?
The principal executive offices are located at 8832 Glendon Way, Rosemead, California 91770.
Filing Stats: 871 words · 3 min read · ~3 pages · Grade level 11.9 · Accepted 2024-10-08 20:33:10
Key Financial Figures
- $0.001 — ch registered Common stock, par value $0.001 par value HFUS OTC Markets Group
Filing Documents
- form8-k.htm (8-K) — 36KB
- 0001493152-24-040500.txt ( ) — 207KB
- hfus-20241007.xsd (EX-101.SCH) — 3KB
- hfus-20241007_lab.xml (EX-101.LAB) — 33KB
- hfus-20241007_pre.xml (EX-101.PRE) — 24KB
- form8-k_htm.xml (XML) — 3KB
From the Filing
UNITED SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): October 7, 2024 HARTFORD CREATIVE GROUP, INC. (Exact name of registrant as specified in its charter) Nevada 000-54439 51-0675116 (State or other jurisdiction (Commission (IRS Employer of incorporation) File Number) Identification No.) 8832 Glendon Way , Rosemead , California 91770 (Address of principal executive offices) (Zip Code) 626 - 321-1915 Registrant's telephone number, including area code HARTFORD GREAT HEALTH CORP. (Former name or former address, if changed since last report) Check the appropriate box below if the Form 8-K is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions: Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) Securities registered pursuant to Section 12(b) of the Act: Title of each class Trading Symbol(s) Name of each exchange on which registered Common stock, par value $0.001 par value HFUS OTC Markets Group Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (240.12b-2 of this chapter). Emerging growth company If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. Appointment of Mr. Jurong Guo and Ms. Yiqian Shen to the Board On October 7, 2024, the holders of a majority of the outstanding shares of Common Stock of the Company, by written consent, elected each of Jurong Guo and Yiqian Shen (each, an " Incoming Director ," and together, the " Incoming Directors ") to the Board, effective immediately. The Board determined that Mr. Guo and Ms. Shen are "independent" directors pursuant to the definition of independence under Rule 5605(a)(2) of the Nasdaq Listing Rules. Mr. Guo, age 61, is a seasoned academic and business executive with a distinguished career. As the Dean of the United Business School (UBI) China and Chairman of the Advisory Committee at Detong Capital, he brings a wealth of experience to his leadership roles. His expertise extends to serving as an Independent Director on multiple publicly listed companies. Prior to his current positions, Mr. Guo has served as the Assistant Dean of Antai College of Economics and Management, Shanghai Jiao Tong University, and the Director of EMBA Program, the Executive Dean of China Enterprise Development Research Institute, the Secretary General of the Academic Committee of the Research Institute of the Ministry of Commerce of the People's Republic of China, the Professor and President of Qingdao Institute of Technology and the Founding President of Shanghai Medical University. Ms. Shen, age 67, is a financial executive with over four decades of experience, holds a degree in accounting from Shanghai University of Finance and Economics.. Throughout her career, Ms. Shen has held key financial leadership positions at leading companies in various industries. Her expertise includes serving as a Financial Director at Shanghai Jingyuan Real Estate Development Co., Ltd., Beijing Aodewei (Shanghai) Consulting Co., Ltd., and Shanghai Sirui Construction Technology Co., Ltd. Prior to these roles, she held positions in accounting and finance at Shanghai No. 19 Cotton Textile Factory and Watanabe Group (Shanghai) International Business Co., Ltd. Ms. Shen's early career in logistics management at the Shanghai Haifeng Farm Brigade provided her with a solid foundation in operations and management. There are no arrangements or understandings pursuant to which the Incoming Directors were selected as directors of the Company and there are no familial relationships between the Incoming Directors and the other directors or executive officers of the Company. Since the beginning of the Company's last fiscal year, the Company and the Incoming Directors have not participated in any transactions, and there are currently no proposed transactions in which the Company or the Incoming Directors, or any person who as a result of the Incoming Director's would be a related person for the pu